Pacific Biosciences
PACB
PACB
266 hedge funds and large institutions have $1.01B invested in Pacific Biosciences in 2024 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 92 increasing their positions, 70 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9.89% less ownership
Funds ownership: 109.2% → 99.31% (-9.9%)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
65% less capital invested
Capital invested by funds: $2.86B → $1.01B (-$1.86B)
Holders
266
Holding in Top 10
3
Calls
$8.01M
Puts
$6.66M
Top Buyers
| 1 | +$35.7M | |
| 2 | +$24.3M | |
| 3 | +$9.05M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$6.71M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$6.25M |
Top Sellers
| 1 | -$76.2M | |
| 2 | -$52.5M | |
| 3 | -$29.8M | |
| 4 |
DC
Decheng Capital
Menlo Park,
California
|
-$28.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$24M |